23 April 2021 | News
Acquires personalized blood testing business MyHealthTest to establish the utility of its new and emerging disruptive tools for personalized preventative healthcare and data-based decision-making
Photo Credit: University of Canberra
Trajan Scientific and Medical (Trajan) has aquired the MyHealthTest blood testing service for an undisclosed sum. The acquisition further boosts Trajan’s ability to deliver analytical measurement services. Trajan will combine its Trajan Nutrition testing facility in Melbourne with MyHealthTest to form a new business unit: Trajan Analytical Services.
“The acquisition of MyHealthTest is the next step for Trajan establishing the utility of its new and emerging disruptive tools for personalized preventative healthcare and data-based decision-making. By combining MyHealthTest with Trajan Nutrition, we are embraceing a world that delivers personalized, preventative healthcare through the empowerment of the individual. Trajan intensly focuses on micro-sampling tools and laboratory automation that can generate data. It’s the data that ultimately is going to be interpreted to provide a view of someone’s health trajectory,” says Trajan CEO Stephen Tomisich.
Trajan is a privately owned Australian company that provides analytical and life science instruments, devices, and components to enable more selective, sensitive and specific measurement and analysis of biological, environmental and food samples. MyHealthTest is a Canberra-based Australian healthcare company that delivers analytical measurement services.
MyHealthTest has expertise in dried blood spot (DBS) technology, an incredibly useful tool for the remote testing of the health of a population because it allows people to take samples of their own blood at home or in the workplace for analysis at MyHealthTest’s pathology laboratory which is currently located in Canberra. MyHealthTest has existing commercial DBS tests for diabetes and thyroid. The DBS tests are widely used for external research projects where remote sampling of study participants is necessary.
The MyHealthTest laboratory is equipped with a range of instruments capable of producing high-quality, accurate and precise data and has been certified by Australia’s National Association of Testing Authorities (NATA).
MyHealthTest also provides a range of clinical laboratory research services to the health industry and research institutions. It has significant experience in the development, validation and verification of immunoassay (ELISA, time-resolved fluorescence), liquid chromatography – mass spectrometry (LC-MS) and biochemistry methods for clinical use.